Caroline Lohrisch

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.

M. Piccart, M. Nooij, R. Paridaens, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

M. Piccart, M. Nooij, L. Beex, 2002, European journal of cancer.

Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?

M. Piccart, F. Cardoso, C. Lohrisch, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.